RGNNF (Renergen) Change In Receivables : $-0.16 Mil (TTM As of Aug. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Renergen Change In Receivables?

Renergen's change in receivables for the quarter that ended in Aug. 2024 was $0.51 Mil. It means Renergen's Accounts Receivable declined by $0.51 Mil from Feb. 2024 to Aug. 2024 .

Renergen's change in receivables for the fiscal year that ended in Feb. 2024 was $-0.03 Mil. It means Renergen's Accounts Receivable increased by $0.03 Mil from Feb. 2023 to Feb. 2024 .

Renergen's Accounts Receivable for the quarter that ended in Aug. 2024 was $1.80 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Renergen's Days Sales Outstanding for the six months ended in Aug. 2024 was 230.70.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Renergen's liquidation value for the six months ended in Aug. 2024 was $-59.75 Mil.

Renergen Change In Receivables Historical Data

The historical data trend for Renergen's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renergen Change In Receivables Chart

Renergen Annual Data

Trend

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Change In Receivables

Get a 7-Day Free Trial

-0.07

-0.13

-1.27

-0.19

-0.03

Renergen Semi-Annual Data
	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24
Change In Receivables	Get a 7-Day Free Trial												-0.34	0.13	0.65	-0.67	0.51

Renergen Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Aug. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.16 Mil.

Renergen (OTCPK:RGNNF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Renergen's Days Sales Outstanding for the quarter that ended in Aug. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.795	/	1.42	*	91
=	230.70

2. In Ben Graham's calculation of liquidation value, Renergen's accounts receivable are only considered to be worth 75% of book value:

Renergen's liquidation value for the quarter that ended in Aug. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5.581	-	66.723	+	0.75 * 1.795	+	0.5 * 0.098
=	-59.75

Renergen Change In Receivables Related Terms

Thank you for viewing the detailed overview of Renergen's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Renergen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Renergen Ltd (OTCPK:RGNNF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

REN:South Africa 9960:Germany RLT:Australia

Address

25 Minerva Avenue, Sandton Gate, Glenadrienne, Sandton, ZAF, 2196

Website

https://www.renergen.co.za

Renergen Ltd is an investment holding company focused on the alternative and renewable energy sectors in South Africa and sub-Saharan Africa. Its reportable segments are the Corporate Head office where all investment decisions are made; Tetra4 which explores, produces, and sells LNG in South Africa; Cryovation which has developed Cryo-VaccTM technology, and enables the safe transportation of vaccines and biologics at extremely low temperatures without the need for electrical power; and the Renergen U.S segment which assists with various fundraising and business development activities of the Group in the U.S market. The majority of the company's revenue is generated from the Tetra4 segment.

Renergen Headlines

No Headlines